Hormones Found In The Brain May Determine How Much You Eat And Affect Obesity And Diabetes

February 20, 1998

DALLAS * February 20, 1998 ** Scientists at UT Southwestern Medical Center at Dallas believe newly discovered hormones produced in the brain may influence development of obesity and diabetes.

The researchers, who discovered the hormones, said in today's issue of Cell that further research into these neuropeptides -- proteins found in nerve cells -- and receptors may reveal ways to inhibit eating. The hormones were found to stimulate the appetite of laboratory rats. The neuropeptides, or ligands, which are called orexin-A and orexin-B, and the receptors, OX1R and OX2R, allude to the Greek word orexis, for appetite.

"These receptors and ligands regulate feeding behavior, which is a very important area of medical research," said Dr. Masashi Yanagisawa, professor of molecular genetics and Howard Hughes Medical Institute (HHMI) investigator. "This is an excellent area for further drug research to determine whether orexins and their G protein-coupled cell-surface receptors can be targeted to suppress eating habits."

In the first part of their investigation, the scientists found the receptors, which are closely related proteins. When bound to ligands, the receptors trigger a G protein, which in turn sets off a series of messages to turn on or turn off genes. Next, they found the two ligands, members of a previously unidentified family of neuropeptides, which bind with OX1R and OX2R to begin the signaling cascade. These proteins are located in a portion of the brain called the lateral hypothalamus, the region that controls appetite.

After determining that they had the locks (receptors) and keys (ligands) that fit together to begin the intercellular communication process, the investigators tested it on rats. They used catheters to administer some of the neuropeptides to the animals' brains and found that the proteins stimulated food consumption.

"When we limited the food intake of the animal, even more of the neuropeptide was produced, which is what we expected of a hormone that physiologically regulates appetite," Yanagisawa said. "The neuron tells the animal it is hungry by producing more orexin peptides. Increased peptides increased the animal's appetite. In other words, it is part of a feedback loop in the biochemical process."

He said an important part of upcoming research will be to produce rodents missing three genes -- one ligand and the two receptor genes -- to see if the rats' appetites can be decreased by inhibiting any of them.

"These neuropeptides are a very plausible molecular basis for some classical experiments on eating habits," Yanagisawa said. "The question is what happens in the brain to control the highly complex feeding behavior, as well as body weight."

The brain translates information it receives from different organs into metabolic-rate changes, which affect how much food people consume and how fast their bodies burn it off.

"The brain is doing a lot of things like a black box in dealing with all this information," Yanagisawa said. Part of this biochemical process involves maintaining equilibrium between food consumption and energy expenditure. This helps determine whether someone becomes obese and/or develops adult-onset diabetes mellitus.

"Now is the time when we start to understand the neural network and the molecular players that form the very complex regulation of this entire biochemical process of appetite," he said. "We believe that neuropeptides, including orexins, are very important components."

Other authors of the study were: Drs. Hirokazu Tanaka and Richard Chemelli, postdoctoral fellows in molecular genetics and HHMI associates; Dr. James Richardson, associate professor of pathology; Dr. Gerald Koslowski, associate professor of physiology; S. Clay Williams, HHMI research technician; Makoto Ishii, a UT Southwestern summer undergraduate fellow; Drs. Takeshi Sakurai, Akira Amemiya and Ichiyo Matsuzaki, former UT Southwestern postdoctoral fellows and HHMI associates, now continuing their studies in Japan; and researchers at SmithKline Beecham Pharmaceuticals.

Grants from the Perot Family Foundation helped fund the research.

UT Southwestern Medical Center

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.